Compare StocksCB vs PFE

Chubb Limited (CB) vs Pfizer, Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-08-03, CB is undervalued at $351, with a DCF intrinsic value of $453 and a margin of safety of 23%. PFE is undervalued at $25, with an intrinsic value of $127985960274 and a margin of safety of 100%. Of the two, PFE has the wider margin of safety.

CB
Chubb Limited
$350.68
VS
PFE
Pfizer, Inc.
$25.01

Rewards

CB
  • Chubb Limited scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Each dollar of retained earnings has created $2.32 of earning power — management is an exceptional capital allocator.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Trailing P/E of 19.1x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

CB
  • FCF yield of 7.8% suggests reasonable valuation assuming continued moderate growth.
  • PEG ratio of 2.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.96 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 2.94 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 1.38 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
CB
PFE
Valuation
$10.49B
Free Cash Flow
$12.38B
7.75%
FCF Yield
N/A
12.42
Trailing P/E
19.09
12.03
Forward P/E
8.85
Quality & Moat
10.87%
ROIC
10.19%
14.82%
ROE
8.31%
31.13%
Gross Margin
74.80%
2.77
PEG Ratio
2.94
Balance Sheet Safety
0.21
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
1.15
Net Debt / EBITDA
2.03
1.16%
Dividend Yield
6.88%
CB: 6Ties: 1PFE: 4
CBPFE

Historical Fundamentals

Learn more →
CB

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
CB
$1.26
created per $1 retained over 3 years
Value Creator
Σ Retained
$24.27B
Δ Market Cap
+$30.61B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-26.34
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CB
22.6% Margin of Safety
Price is 22.6% below estimated fair value
Current Price: $350.68
Fair Value: $453.06
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
100.0% Margin of Safety
Price is 100.0% below estimated fair value
Current Price: $25.01
Fair Value: $127985960274.09
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CB

What growth rate is the market pricing in at $351?

+3.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +3.3%

The market implies +3.6% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +3.3%, reflecting heavy growth investment expected to generate future returns.

PFE

What growth rate is the market pricing in at $25?

-14.2%
Market-Implied Owner Earnings Growth
Standard FCF implies -15.0%

The market implies -14.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding -15.0%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
CB
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
CB
-2.47
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CB
Insiders 9.5%Institutions 85.1%Retail & Other 5.4%
No. of Institutional Holders2,718
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.5%Retail & Other 30.4%
No. of Institutional Holders3,661
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CB
0
Buys (3M)
0
Buys (12M)
CORBAT MICHAEL L
Director
$114,665
@ $269.80 · 2025-07-25
KEOGH JOHN W
President
$2.87M
@ $293.01 · 2025-06-06
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CB
4
Sells (3M)
17
Sells (12M)
Total value (12M): $51.61M
WAYLAND JOSEPH F
General Counsel
$3.10M
@ $364.54 · 2026-07-28
ORTEGA JUAN LUIS
Officer
$1.25M
@ $322.08 · 2026-06-08
KEOGH JOHN W
President
$7.39M
@ $321.51 · 2026-05-27
ATIEH MICHAEL G
Director
$190,468
@ $329.53 · 2026-05-21
STEIMER OLIVIER
Director
$658,600
@ $329.30 · 2026-03-19
OHSIEK GEORGE F
Officer
$250,408
@ $325.21 · 2026-03-06
JOHNS BRYCE L
Officer
$504,925
@ $336.62 · 2026-03-04
WAYLAND JOSEPH F
General Counsel
$2.57M
@ $336.44 · 2026-03-03
OHSIEK GEORGE F
Officer
$1.67M
@ $325.43 · 2026-02-13
GREENBERG EVAN G
Chief Executive Officer
$5.00M
@ $335.09 · 2026-02-12
BOROUGHS TIMOTHY ALAN
Chief Investment Officer
$9.23M
@ $331.98 · 2026-02-06
GREENBERG EVAN G
Chief Executive Officer
$4.99M
@ $331.47 · 2026-02-05
ORTEGA JUAN LUIS
Officer
$1.29M
@ $295.04 · 2025-12-02
ORTEGA JUAN LUIS
Officer
$253,666
@ $293.59 · 2025-12-02
LUPICA JOHN J
Officer
$4.85M
@ $296.45 · 2025-11-14
WAYLAND JOSEPH F
General Counsel
$1.73M
@ $297.08 · 2025-11-13
LUPICA JOHN J
Officer
$6.66M
@ $281.00 · 2025-10-27
LUPICA JOHN J
Officer
$1.60M
@ $290.06 · 2025-07-01
ATIEH MICHAEL G
Director
$154,707
@ $287.56 · 2025-06-16
WAYLAND JOSEPH F
General Counsel
$1.54M
@ $293.16 · 2025-06-04
KEOGH JOHN W
President
$24.69M
@ $290.24 · 2025-05-21
ORTEGA JUAN LUIS
Officer
$1.90M
@ $292.13 · 2025-05-20
WAYLAND JOSEPH F
General Counsel
$3.61M
@ $294.82 · 2025-03-20
BOROUGHS TIMOTHY ALAN
Officer
$4.37M
@ $296.12 · 2025-03-18
OHSIEK GEORGE F
Officer
$221,583
@ $290.41 · 2025-03-14
WAYLAND JOSEPH F
General Counsel
$2.87M
@ $286.96 · 2025-03-04
OHSIEK GEORGE F
Officer
$269,503
@ $267.63 · 2025-02-11
GREENBERG EVAN G
Chief Executive Officer
$17.55M
@ $288.42 · 2024-09-09
WAYLAND JOSEPH F
General Counsel
$1.89M
@ $287.07 · 2024-09-05
ATIEH MICHAEL G
Director
$75,035
@ $287.49 · 2024-09-03
LUPICA JOHN J
Officer
$4.28M
@ $285.49 · 2024-09-03
ORTEGA JUAN LUIS
Officer
$1.07M
@ $273.06 · 2024-08-20
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CB
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(52/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CB
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (52)
View CB Full AnalysisView PFE Full Analysis

Frequently Asked Questions: CB vs PFE

Is Chubb Limited or Pfizer, Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a 100.0% margin of safety (intrinsic value $127985960274 vs. price $25), compared to CB's 22.6% margin of safety (intrinsic $453 vs. $351).

Which stock has a wider economic moat, Chubb Limited or Pfizer, Inc.?

CB scores 100/100 (Wide moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Chubb Limited in financial distress?

CB's Altman Z-Score of 1.0 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 1.4 (Distress zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Chubb Limited or Pfizer, Inc.?

CB earns 10.9% ROIC versus PFE's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Chubb Limited's or Pfizer, Inc.'s?

CB's dividend earns a safety score of 94/100 (Very Safe), compared to PFE's 24/100 (Unsafe). CB has raised its dividend for 3 consecutive years.

CB vs PFE: Which Is the Better Buy in 2026? | SafetyMargin.io